Polaryx Therapeutics, Inc. Common Stock ( PLYX) - Key Metrics
PLYX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$0.05 | $0 | $0 |
| 2025Q4 | $0 | -$0.03 | -$0.03 | -$0.03 |
| 2025Q3 | $0 | -$0.01 | $0 | $0 |
| 2025Q2 | $0 | -$0.01 | $0 | $0 |
| 2025Q1 | $0 | -$0.03 | $0 | $0 |
PLYX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -35.06 |
| 2025Q4 | 0% | -276.90 |
| 2025Q3 | 0% | -1151.32 |
| 2025Q2 | 0% | -1650.94 |
| 2025Q1 | 0% | -327.72 |
PLYX
Price: $2.07
52 week price:
Earnings Per Share: -0.14 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 98.9 million